Isarna Therapeutics
PrivateLast Round
VC Round
Apr 25, 2014
Total Funding Raised
$38M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Isarna Therapeutics operates in Healthcare & Life Sciences and is based in Munich. Its latest recorded funding round was a VC Round in April 2014.
Isarna Therapeutics is a drug discovery company that develops transforming growth factor beta inhibitors designed to treat ophthalmic and fibrotic diseases and fight cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Isarna Therapeutics Comparables
Compare Isarna Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PharmaMar | 79% | |
| Biogen | 71% | |
| Annexon Biosciences | 71% |
For institutional investors. Book with your work email.
Isarna Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Apr 25, 2014 | ||||
| VC Round | Jan 7, 2014 | ||||
| VC Round | Jul 6, 2011 | ||||
| VC Round | Mar 15, 2010 | ||||
| Series D | Nov 9, 2007 | ||||
VC Round | Nov 30, 2005 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Isarna Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| tbg Technologie-Beteiligungs-GmbH | VC Round |
| MIG AG | VC Round |
| Bayern Kapital | VC Round |
| MIG Fonds | VC Round, Series D |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 29, 2026
Monthly visitors grew 468% MoM, from 259 to 1.5K.
- Feb 3, 2026
Monthly visitors increased 839% MoM.
For institutional investors. Book with your work email.
Isarna Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Isarna Therapeutics's valuation, stock price, and market status.
Is Isarna Therapeutics a public or private company?
Isarna Therapeutics is a private company.
What is the current stock price of Isarna Therapeutics?
Isarna Therapeutics is a private company, so its shares have no public market price. Caplight tracks Isarna Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Isarna Therapeutics worth (valuation)?
Valuation information for Isarna Therapeutics is not publicly available.
Can I buy Isarna Therapeutics stock?
Isarna Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Isarna Therapeutics's last funding round?
Isarna Therapeutics's most recent funding round was VC Round on April 25, 2014.
Who are the main investors in Isarna Therapeutics?
Key investors in Isarna Therapeutics include MIG Fonds.
Will Isarna Therapeutics IPO soon?
No public IPO plans have been announced for Isarna Therapeutics.
How can I track Isarna Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Isarna Therapeutics's shares on secondary markets.